Eli Lilly Expands Gene Therapy Portfolio to Eye Care with $475M MeiraGTx Deal
Eli Lilly bets big on the future of gene therapy for vision restoration. Eli Lilly is making another bold move…
Retina Roundup at AAO 2025: Fresh data, Familiar Challenges and the Future of Eye Care
From anti-VEGF debates to gene therapy dreams, this retina session delivered a masterclass in precision, progress and perspective. The retina…
latest posts
